Radiation Injury Treatment Network (RITN) Workshop
The Radiation Injury Treatment Network seeks to increase awareness and understanding of the tremendous environmental, social, and medical cost of a mass casualty incident resulting from a nuclear or radiological disaster, such as a deliberate attack or complications from a natural disaster. This workshop will engage attendees through discussions about recent developments in the mitigation and treatment of radiation damage including: patient assessment, biomarkers and biodosimetry, suitability of animal models, small molecules, growth factors, and cells as mitigators, as well as their mechanisms of action in radiation-damaged tissues, late effects of acute and prolonged exposure, survivorship issues, and future developments. Additionally, the workshop will include the open sharing of lessons learned from preparedness efforts in a collaborative environment to allow attendees to capitalize upon peers efforts at their institutions.
The Medical College of Wisconsin designates this activity for up to 8.75 hours of participation for continuing education for allied health professionals.
Target Audience
Physicians, and other clinicians, support staff, emergency managers, research scientists, and appropriate federal agency staff involved in radiation response and treatment of patients with bone marrow toxicity.
Learning Objectives
- Discuss progress in research on radiological countermeasures and biodosimetry.
- Explain best practices from RITN hospitals.
- Evaluate medical and societal effects from a pertinent recent incident.
- Describe current gaps identified in federal planning efforts to prepare for a radiological disaster.
Name | Company | Role |
Anita D'Souza, MD | Celgene, Merck | Research |
Cullen Case, MD | 3M | Spouse/Employment |
Available Credit
- 8.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 8.75 Hours of ParticipationHours of Participation credit.